NCT01554852 Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients Status UNKNOWN Phase PHASE3
NCT01554189 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) Status TERMINATED Phase PHASE1
NCT01554176 Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022) Status TERMINATED Phase PHASE2
NCT01552122 Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050) Status WITHDRAWN Phase PHASE3
NCT01550224 Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT01549496 A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers Status WITHDRAWN Phase PHASE1
NCT01547312 Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) Status WITHDRAWN Phase PHASE1
NCT01545388 Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136) Status COMPLETED Phase PHASE3
NCT01544920 Safety and Efficacy of Boceprevir/Peginterferon Alfa-2a/Ribavirin in Interleukin-28B CC Allele-Positive Chronic Hepatitis C Virus (HCV) Genotype 1 Participants (P07755) Status COMPLETED Phase PHASE3
NCT01544582 Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518) Status COMPLETED Phase N/A
NCT01544478 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Status COMPLETED Phase PHASE4
NCT01543620 Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT01537900 A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010) Status COMPLETED Phase PHASE1
NCT01537757 A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535]) Status COMPLETED Phase PHASE1
NCT01537120 Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) Status COMPLETED Phase PHASE1
NCT01536405 Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) Status COMPLETED Phase PHASE3
NCT01535794 HPV Vaccine Acceptability Among Young Men Who Have Sex With Men Status COMPLETED Phase N/A
NCT01534637 Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer Status COMPLETED Phase PHASE2